MIMEDX GROUP, INC. (MDXG) 8-K Current Report: February 25, 2026
Filed: February 25, 2026
Health Care
Surgical & Medical Instruments & ApparatusMIMEDX GROUP, INC. (MDXG) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
MIMEDX GROUP, INC. 8-K Feb 25, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q1 2025 earnings press release filed via Exhibit — refer to attached exhibit for revenue, earnings, and guidance figures
- • Furnished under Item 2.02, meaning not "filed" for liability purposes under Exchange Act Section 18
- • Standard Reg FD-compliant disclosure; no forward-looking obligation assumed by company
Item 7.01 · Regulation FD Disclosure
- • Q4 and full-year 2025 earnings call scheduled Feb 25, 2026 at 4:30 PM ET
- • Slide deck (Exhibit 99.2) and updated investor presentation (Exhibit 99.3) accompany the call
- • Key financials for FY2025 will be disclosed — monitor exhibits for revenue, margin, and guidance figures
Get deeper insights on MIMEDX GROUP, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.